Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Monroe Capital (MRCC) Shares Outstanding (Diluted Average) (2020 - 2025)

Monroe Capital's Shares Outstanding (Diluted Average) history spans 6 years, with the latest figure at $21.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) changed 0.0% year-over-year to $21.7 million; the TTM value through Dec 2025 reached $21.7 million, changed 0.0%, while the annual FY2025 figure was $21.7 million, 0.0% changed from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $21.7 million at Monroe Capital, roughly flat from $21.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $21.7 million in Q1 2022 and bottomed at $21.5 million in Q4 2021.
  • The 5-year median for Shares Outstanding (Diluted Average) is $21.7 million (2022), against an average of $21.6 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) increased 2.53% in 2021 before it changed 0.0% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $21.5 million in 2021, then rose by 0.99% to $21.7 million in 2022, then changed by 0.0% to $21.7 million in 2023, then changed by 0.0% to $21.7 million in 2024, then changed by 0.0% to $21.7 million in 2025.
  • Per Business Quant, the three most recent readings for MRCC's Shares Outstanding (Diluted Average) are $21.7 million (Q4 2025), $21.7 million (Q3 2025), and $21.7 million (Q2 2025).